Substance abuse in schizophrenia: A review

Peter F. Buckley

Research output: Contribution to journalReview article

164 Citations (Scopus)

Abstract

Approximately half of the patients who suffer from schizophrenia are also substance abusers at some time during their illness. The motivational drive toward abusive consumption is compounded in individuals with schizophrenia who turn toward substances with reinforcing properties to alleviate aspects of psychosis. This review examines the prevalence, etiology, and clinical effects of substance abuse (e.g., alcohol, nicotine, cocaine) among individuals with schizophrenia. Clearly, substance abuse persists despite and in spite of treatment with typical antipsychotics. The efficacy of newer generation antipsychotics in the reduction of substance abuse among the schizophrenic population has yet to be established, but clozapine has been shown to reduce alcohol, smoking, and cocaine use. Hence, clozapine is a therapeutic option for dually diagnosed patients because of its superior efficacy relative to conventional neuroleptics and its capacity to control substance abuse.

Original languageEnglish (US)
Pages (from-to)26-30
Number of pages5
JournalJournal of Clinical Psychiatry
Volume59
Issue numberSUPPL. 3
StatePublished - May 12 1998

Fingerprint

Substance-Related Disorders
Schizophrenia
Antipsychotic Agents
Clozapine
Cocaine
Alcohols
Nicotine
Psychotic Disorders
Smoking
Therapeutics
Population

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Buckley, P. F. (1998). Substance abuse in schizophrenia: A review. Journal of Clinical Psychiatry, 59(SUPPL. 3), 26-30.

Substance abuse in schizophrenia : A review. / Buckley, Peter F.

In: Journal of Clinical Psychiatry, Vol. 59, No. SUPPL. 3, 12.05.1998, p. 26-30.

Research output: Contribution to journalReview article

Buckley, PF 1998, 'Substance abuse in schizophrenia: A review', Journal of Clinical Psychiatry, vol. 59, no. SUPPL. 3, pp. 26-30.
Buckley, Peter F. / Substance abuse in schizophrenia : A review. In: Journal of Clinical Psychiatry. 1998 ; Vol. 59, No. SUPPL. 3. pp. 26-30.
@article{bf692294843b42ab8d015cd56bd2cb7f,
title = "Substance abuse in schizophrenia: A review",
abstract = "Approximately half of the patients who suffer from schizophrenia are also substance abusers at some time during their illness. The motivational drive toward abusive consumption is compounded in individuals with schizophrenia who turn toward substances with reinforcing properties to alleviate aspects of psychosis. This review examines the prevalence, etiology, and clinical effects of substance abuse (e.g., alcohol, nicotine, cocaine) among individuals with schizophrenia. Clearly, substance abuse persists despite and in spite of treatment with typical antipsychotics. The efficacy of newer generation antipsychotics in the reduction of substance abuse among the schizophrenic population has yet to be established, but clozapine has been shown to reduce alcohol, smoking, and cocaine use. Hence, clozapine is a therapeutic option for dually diagnosed patients because of its superior efficacy relative to conventional neuroleptics and its capacity to control substance abuse.",
author = "Buckley, {Peter F.}",
year = "1998",
month = "5",
day = "12",
language = "English (US)",
volume = "59",
pages = "26--30",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Substance abuse in schizophrenia

T2 - A review

AU - Buckley, Peter F.

PY - 1998/5/12

Y1 - 1998/5/12

N2 - Approximately half of the patients who suffer from schizophrenia are also substance abusers at some time during their illness. The motivational drive toward abusive consumption is compounded in individuals with schizophrenia who turn toward substances with reinforcing properties to alleviate aspects of psychosis. This review examines the prevalence, etiology, and clinical effects of substance abuse (e.g., alcohol, nicotine, cocaine) among individuals with schizophrenia. Clearly, substance abuse persists despite and in spite of treatment with typical antipsychotics. The efficacy of newer generation antipsychotics in the reduction of substance abuse among the schizophrenic population has yet to be established, but clozapine has been shown to reduce alcohol, smoking, and cocaine use. Hence, clozapine is a therapeutic option for dually diagnosed patients because of its superior efficacy relative to conventional neuroleptics and its capacity to control substance abuse.

AB - Approximately half of the patients who suffer from schizophrenia are also substance abusers at some time during their illness. The motivational drive toward abusive consumption is compounded in individuals with schizophrenia who turn toward substances with reinforcing properties to alleviate aspects of psychosis. This review examines the prevalence, etiology, and clinical effects of substance abuse (e.g., alcohol, nicotine, cocaine) among individuals with schizophrenia. Clearly, substance abuse persists despite and in spite of treatment with typical antipsychotics. The efficacy of newer generation antipsychotics in the reduction of substance abuse among the schizophrenic population has yet to be established, but clozapine has been shown to reduce alcohol, smoking, and cocaine use. Hence, clozapine is a therapeutic option for dually diagnosed patients because of its superior efficacy relative to conventional neuroleptics and its capacity to control substance abuse.

UR - http://www.scopus.com/inward/record.url?scp=0031977231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031977231&partnerID=8YFLogxK

M3 - Review article

C2 - 9541335

AN - SCOPUS:0031977231

VL - 59

SP - 26

EP - 30

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - SUPPL. 3

ER -